<DOC>
	<DOCNO>NCT01197547</DOCNO>
	<brief_summary>This clinical registry FDA approve device system call Genesys Hydro ThermAblatorTM ( HTA ) system ( Boston Scientific ) . The HTA system 's intend use insert , trained physician , uterus , fill circulate fluid warm enough change characteristic uterine lining . This do anticipate result improve menstrual bleeding symptom . The purpose FDA-mandated registry obtain clinical experience use Genesys HTAâ„¢ system , normal clinical condition , document safety technical reliability .</brief_summary>
	<brief_title>Registry Study Genesys HTA Treatment Menorrhagia</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>Subject must meet approved indication use consider registry . All subject contraindicate treatment Genesys HTA System per Directions Use exclude : 1 . The subject pregnant want pregnant future 2 . The subject know suspected endometrial carcinoma premalignant change endometrium , adenomatous hyperplasia 3 . The subject active pelvic inflammatory disease pyosalpinx 4 . The subject hydrosalpinx 5 . The subject tight cervical seal establish maintain around procedure sheath 6 . The subject anatomical condition ( e.g . history previous classical cesarean section transmural myomectomy ) pathologic condition ( e.g . long term medical therapy ) could lead weaken myometrium 7 . The subject intrauterine device place 8 . The subject active genital urinary tract infection ( e.g . cervicitis , endometritis , vaginitis , cystitis , etc . ) time treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Menorrhagia</keyword>
</DOC>